{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:31:41Z","timestamp":1792110701072,"version":"4.4.0"},"reference-count":29,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2024]]},"DOI":"10.1620\/tjem.2023.j103","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T22:13:08Z","timestamp":1703715188000},"page":"191-199","source":"Crossref","is-referenced-by-count":6,"title":["Comparative Efficacy of Augmenting Escitalopram with Modified Electroconvulsive Therapy or High-Frequency Repetitive Transcranial Magnetic Stimulation on Depressive Symptoms, Quality of Life, and Cognitive Function in Treatment-Resistant Depression"],"prefix":"10.1620","volume":"262","author":[{"given":"Bo-Wen","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Wenzhou Seventh People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Wenzhou Seventh People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Ali, M.K. &amp; Lam, R.W. (2011)  Comparative efficacy of escitalopram in the treatment of major depressive disorder.  <i>Neuropsychiatr. Dis. Treat.<\/i>, 7, 39-49.","DOI":"10.2147\/NDT.S12531"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Alkahtani, M.E., Aodah, A.H., Abu Asab, O.A., Basit, A.W., Orlu, M. &amp; Tawfik, E.A. (2021)  Fabrication and characterization of fast-dissolving films containing escitalopram\/quetiapine for the treatment of major depressive disorder.  <i>Pharmaceutics<\/i>, 13, 891.","DOI":"10.3390\/pharmaceutics13060891"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Aydin, E.P., Genc, A., Dalkiran, M., Uyar, E.T., Deniz, I., Ozer, O.A. &amp; Karamustafalioglu, K.O. (2018)  Thioredoxin is not a marker for treatment-resistance depression but associated with cognitive function: an rTMS study.  <i>Prog. Neuropsychopharmacol. Biol. Psychiatry<\/i>, 80, 322-328.","DOI":"10.1016\/j.pnpbp.2017.04.025"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bretlau, L.G., Lunde, M., Lindberg, L., Unden, M., Dissing, S. &amp; Bech, P. (2008)  Repetitive transcranial magnetic stimulation (rTMS)  in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.  <i>Pharmacopsychiatry<\/i>, 41, 41-47.","DOI":"10.1055\/s-2007-993210"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Cano, M., Lee, E., Polanco, C., Barbour, T., Ellard, K.K., Andreou, B., Uribe, S., Henry, M.E., Seiner, S., Cardoner, N., Soriano-Mas, C. &amp; Camprodon, J.A. (2023)  Brain volumetric correlates of electroconvulsive therapy versus transcranial magnetic stimulation for treatment-resistant depression.  <i>J. Affect. Disord.<\/i>, 333, 140-146.","DOI":"10.1016\/j.jad.2023.03.093"},{"key":"6","unstructured":"Carpenter, L.L., Friehs, G.M., Tyrka, A.R., Rasmussen, S., Price, L.H. &amp; Greenberg, B.D. (2006)  Vagus nerve stimulation and deep brain stimulation for treatment resistant depression.  <i>Med. Health. R. I.<\/i>, 89, 137, 140-141."},{"key":"7","doi-asserted-by":"crossref","unstructured":"Chen, X., Zhang, T., Shan, X., Yang, Q., Zhang, P., Zhu, H., Jiang, F., Liu, C., Li, Y., Li, W., Xu, J. &amp; Shen, H. (2022)  High-frequency repetitive transcranial magnetic stimulation alleviates the cognitive side effects of electroconvulsive therapy in major depression.  <i>Front. Psychiatry<\/i>, 13, 1002809.","DOI":"10.3389\/fpsyt.2022.1002809"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Coetzer, R. (2019)  Depression, memory and electroconvulsive therapy.  <i>BJPsych Bull.<\/i>, 43, 51-53.","DOI":"10.1192\/bjb.2018.59"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Guan, M., Liu, X., Guo, L., Zhang, R., Tan, Q., Wang, H. &amp; Wang, H. (2021)  Improved pre-attentive processing with occipital rTMS treatment in major depressive disorder patients revealed by MMN.  <i>Front. Hum. Neurosci.<\/i>, 15, 648816.","DOI":"10.3389\/fnhum.2021.648816"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Ilic, I., Sipetic, S., Grujicic, J., Macuzic, I.Z., Kocic, S. &amp; Ilic, M. (2019)  Psychometric properties of the World Health Organization\u2019s Quality of Life (WHOQOL-BREF)  questionnaire in medical students.  <i>Medicina <\/i>(<i>Kaunas<\/i>), 55, 772.","DOI":"10.3390\/medicina55120772"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Krause-Sorio, B., Siddarth, P., Kilpatrick, L., Laird, K.T., Milillo, M.M., Ercoli, L., Narr, K.L. &amp; Lavretsky, H. (2020)  Combined treatment with escitalopram and memantine increases gray matter volume and cortical thickness compared to escitalopram and placebo in a pilot study of geriatric depression.  <i>J. Affect. Disord.<\/i>, 274, 464-470.","DOI":"10.1016\/j.jad.2020.05.092"},{"key":"12","unstructured":"Landy, K., Rosani, A. &amp; Estevez, R. (2023)  Escitalopram.  In <i>StatPearls<\/i>, Treasure Island, FL."},{"key":"13","doi-asserted-by":"crossref","unstructured":"Li, Z., Wu, T.T., Xiong, Y.T., Zhang, X.Y., Bao, Y.P., Guo, L.B., Han, B.J., Li, S.X., Wang, Y.F., Lu, L. &amp; Wang, X.Q. (2023)  A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine.  <i>Front. Psychiatry<\/i>, 14, 1188175.","DOI":"10.3389\/fpsyt.2023.1188175"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Masdrakis, V.G., Oulis, P., Florakis, A., Valamoutopoulos, T., Markatou, M. &amp; Papadimitriou, G.N. (2008)  The safety of the electroconvulsive therapy-escitalopram combination.  <i>J. ECT<\/i>, 24, 289-291.","DOI":"10.1097\/YCT.0b013e31816ba99d"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Mi, K., Guo, Q., Xu, B.Y., Wang, M. &amp; Bi, H. (2021)  Efficacy of hyperbaric oxygen combined with escitalopram in depression and its effect on cognitive function.  <i>Pak. J. Med. Sci.<\/i>, 37, 1054-1057.","DOI":"10.12669\/pjms.37.4.3993"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Moirand, R., Galvao, F., Lecompte, M., Poulet, E., Haesebaert, F. &amp; Brunelin, J. (2018)  Usefulness of the Montreal Cognitive Assessment (MoCA)  to monitor cognitive impairments in depressed patients receiving electroconvulsive therapy.  <i>Psychiatry Res.<\/i>, 259, 476-481.","DOI":"10.1016\/j.psychres.2017.11.022"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Nygren, A., Reutfors, J., Brandt, L., Boden, R., Nordenskjold, A. &amp; Tiger, M. (2023)  Response to electroconvulsive therapy in treatment-resistant depression: nationwide observational follow-up study.  <i>BJPsych Open<\/i>, 9, e35.","DOI":"10.1192\/bjo.2023.5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"O\u2019Driscoll, C. &amp; Shaikh, M. (2017)  Cross-cultural applicability of the Montreal Cognitive Assessment (MoCA): a systematic review.  <i>J. Alzheimers Dis.<\/i>, 58, 789-801.","DOI":"10.3233\/JAD-161042"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Papp, M., Cubala, W.J., Swiecicki, L., Newman-Tancredi, A. &amp; Willner, P. (2022)  Perspectives for therapy of treatment-resistant depression.  <i>Br. J. Pharmacol.<\/i>, 179, 4181-4200.","DOI":"10.1111\/bph.15596"},{"key":"20","doi-asserted-by":"publisher","unstructured":"Ramasubbu, R., Brown, E.C., Selby, B., McGirr, A., Cole, J., Hassan, H. &amp; McAusland, L. (2023)  Accelerated sequential bilateral theta-burst stimulation in major depression: an open trial.  <i>Eur. Arch. Psychiatry Clin. Neurosci.<\/i>, doi: 10.1007\/s00406-023-01648-0 [Epub ahead of print].","DOI":"10.1007\/s00406-023-01648-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Rossini, D., Magri, L., Lucca, A., Giordani, S., Smeraldi, E. &amp; Zanardi, R. (2005)  Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial.  <i>J. Clin. Psychiatry<\/i>, 66, 1569-1575.","DOI":"10.4088\/JCP.v66n1212"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Ryan, K.M., Lynch, M. &amp; McLoughlin, D.M. (2022)  Blood cell ratios in mood and cognitive outcomes following electroconvulsive therapy.  <i>J. Psychiatr. Res.<\/i>, 156, 729-736.","DOI":"10.1016\/j.jpsychires.2022.11.016"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Schulze-Rauschenbach, S.C., Harms, U., Schlaepfer, T.E., Maier, W., Falkai, P. &amp; Wagner, M. (2005)  Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression.  <i>Br. J. Psychiatry<\/i>, 186, 410-416.","DOI":"10.1192\/bjp.186.5.410"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Vasavada, M.M., Leaver, A.M., Njau, S., Joshi, S.H., Ercoli, L., Hellemann, G., Narr, K.L. &amp; Espinoza, R. (2017)  Short- and long-term cognitive outcomes in patients with major depression treated with electroconvulsive therapy.  <i>J. ECT<\/i>, 33, 278-285.","DOI":"10.1097\/YCT.0000000000000426"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Vida, R.G., Saghy, E., Bella, R., Kovacs, S., Erdosi, D., Jozwiak-Hagymasy, J., Zemplenyi, A., Tenyi, T., Osvath, P. &amp; Voros, V. (2023)  Efficacy of repetitive transcranial magnetic stimulation (rTMS)  adjunctive therapy for major depressive disorder (MDD)  after two antidepressant treatment failures: meta-analysis of randomized sham-controlled trials.  <i>BMC Psychiatry<\/i>, 23, 545.","DOI":"10.1186\/s12888-023-05033-y"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Vinberg, M., Weikop, P., Olsen, N.V., Kessing, L.V. &amp; Miskowiak, K. (2016)  Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: a randomised controlled study.  <i>Brain Behav. Immun.<\/i>, 57, 53-57.","DOI":"10.1016\/j.bbi.2016.05.006"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Weissman, C.R., Bermudes, R.A., Voigt, J., Liston, C., Williams, N., Blumberger, D.M., Fitzgerald, P.B. &amp; Daskalakis, Z.J. (2023)  Repetitive transcranial magnetic stimulation for treatment-resistant depression: mismatch of evidence and insurance coverage policies in the United States.  <i>J. Clin. Psychiatry<\/i>, 84, 22com14575.","DOI":"10.4088\/JCP.22com14575"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Yamazaki, R., Matsuda, Y., Oba, M., Oi, H. &amp; Kito, S. (2023)  Maintenance repetitive transcranial magnetic stimulation (rTMS)  therapy for treatment-resistant depression: a study protocol of a multisite, prospective, non-randomized longitudinal study.  <i>BMC Psychiatry<\/i>, 23, 437.","DOI":"10.1186\/s12888-023-04944-0"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Yildiz, T., Oguzhanoglu, N.K. &amp; Topak, O.Z. (2023)  Cognitive outcomes of transcranial magnetic stimulation in treatment-resistant depression: a randomized controlled study.  <i>Turk. J. Med. Sci.<\/i>, 53, 253-263.","DOI":"10.55730\/1300-0144.5580"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/262\/3\/262_2023.J103\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T03:24:28Z","timestamp":1710559468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/262\/3\/262_2023.J103\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2023.j103","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"2023.J103"}}